TY - JOUR AU - Sanmamed, M. F. AU - Chen, L. PY - 2018 DA - 2018// TI - A paradigm shift in Cancer immunotherapy: from enhancement to normalization JO - Cell. VL - 175 UR - https://doi.org/10.1016/j.cell.2018.09.035 DO - 10.1016/j.cell.2018.09.035 ID - Sanmamed2018 ER - TY - JOUR AU - Ribas, A. AU - Wolchok, J. D. PY - 2018 DA - 2018// TI - Cancer immunotherapy using checkpoint blockade JO - Science (New York, NY) VL - 359 UR - https://doi.org/10.1126/science.aar4060 DO - 10.1126/science.aar4060 ID - Ribas2018 ER - TY - JOUR AU - Hegde, P. S. AU - Chen, D. S. PY - 2020 DA - 2020// TI - Top 10 challenges in Cancer immunotherapy JO - Immunity. VL - 52 UR - https://doi.org/10.1016/j.immuni.2019.12.011 DO - 10.1016/j.immuni.2019.12.011 ID - Hegde2020 ER - TY - JOUR AU - Jing, X. AU - Yang, F. AU - Shao, C. PY - 2019 DA - 2019// TI - Role of hypoxia in cancer therapy by regulating the tumor microenvironment JO - Mol Cancer VL - 18 UR - https://doi.org/10.1186/s12943-019-1089-9 DO - 10.1186/s12943-019-1089-9 ID - Jing2019 ER - TY - JOUR AU - Vaupel, P. AU - Multhoff, G. PY - 2017 DA - 2017// TI - Accomplices of the Hypoxic Tumor Microenvironment Compromising Antitumor Immunity: Adenosine, Lactate, Acidosis, Vascular Endothelial Growth Factor, Potassium Ions, and Phosphatidylserine JO - Front Immunol VL - 8 UR - https://doi.org/10.3389/fimmu.2017.01887 DO - 10.3389/fimmu.2017.01887 ID - Vaupel2017 ER - TY - JOUR AU - McDonald, P. C. AU - Chafe, S. C. AU - Dedhar, S. PY - 2016 DA - 2016// TI - Overcoming hypoxia-mediated tumor progression: combinatorial approaches targeting pH regulation, Angiogenesis and Immune Dysfunction JO - Front Cell Dev Biol VL - 4 UR - https://doi.org/10.3389/fcell.2016.00027 DO - 10.3389/fcell.2016.00027 ID - McDonald2016 ER - TY - JOUR AU - Qiu, G. Z. AU - Jin, M. Z. AU - Dai, J. X. PY - 2017 DA - 2017// TI - Reprogramming of the tumor in the hypoxic niche: the emerging concept and associated therapeutic strategies JO - Trends Pharmacol Sci VL - 38 UR - https://doi.org/10.1016/j.tips.2017.05.002 DO - 10.1016/j.tips.2017.05.002 ID - Qiu2017 ER - TY - JOUR AU - Phung, C. D. AU - Tran, T. H. AU - Pham, L. M. PY - 2020 DA - 2020// TI - Current developments in nanotechnology for improved cancer treatment, focusing on tumor hypoxia JO - J Control Release VL - 324 UR - https://doi.org/10.1016/j.jconrel.2020.05.029 DO - 10.1016/j.jconrel.2020.05.029 ID - Phung2020 ER - TY - JOUR AU - Zhou, T. -. J. AU - Xing, L. AU - Fan, Y. -. T. PY - 2019 DA - 2019// TI - Light triggered oxygen-affording engines for repeated hypoxia-resistant photodynamic therapy JO - J Control Release VL - 307 UR - https://doi.org/10.1016/j.jconrel.2019.06.016 DO - 10.1016/j.jconrel.2019.06.016 ID - Zhou2019 ER - TY - JOUR AU - Azimi, I. AU - Petersen, R. M. AU - Thompson, E. W. PY - 2017 DA - 2017// TI - Hypoxia-induced reactive oxygen species mediate N-cadherin and SERPINE1 expression, EGFR signalling and motility in MDA-MB-468 breast cancer cells JO - Sci Rep VL - 7 UR - https://doi.org/10.1038/s41598-017-15474-7 DO - 10.1038/s41598-017-15474-7 ID - Azimi2017 ER - TY - JOUR AU - Chouaib, S. AU - Noman, M. Z. AU - Kosmatopoulos, K. PY - 2017 DA - 2017// TI - Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer JO - Oncogene. VL - 36 UR - https://doi.org/10.1038/onc.2016.225 DO - 10.1038/onc.2016.225 ID - Chouaib2017 ER - TY - STD TI - Abou Khouzam R, Goutham HV, Zaarour RF, et al. Integrating tumor hypoxic stress in novel and more adaptable strategies for cancer immunotherapy. Semin Cancer Biol. 2020. ID - ref12 ER - TY - JOUR AU - Noman, M. Z. AU - Hasmim, M. AU - Lequeux, A. PY - 2019 DA - 2019// TI - Improving Cancer immunotherapy by targeting the hypoxic tumor microenvironment: new opportunities and challenges JO - Cells. VL - 8 UR - https://doi.org/10.3390/cells8091083 DO - 10.3390/cells8091083 ID - Noman2019 ER - TY - JOUR AU - Duffy, M. J. AU - Crown, J. PY - 2019 DA - 2019// TI - Biomarkers for predicting response to immunotherapy with immune checkpoint inhibitors in Cancer patients JO - Clin Chem VL - 65 UR - https://doi.org/10.1373/clinchem.2019.303644 DO - 10.1373/clinchem.2019.303644 ID - Duffy2019 ER - TY - STD TI - Feng J, Byrne NM, Al Jamal W, et al. Exploiting Current Understanding of Hypoxia Mediated Tumour Progression for Nanotherapeutic Development. Cancers. 2019;11(12). . ID - ref15 ER - TY - JOUR AU - Bosco, M. C. AU - D'Orazi, G. AU - Bufalo, D. PY - 2020 DA - 2020// TI - Targeting hypoxia in tumor: a new promising therapeutic strategy JO - J Exp Clin Cancer Res VL - 39 UR - https://doi.org/10.1186/s13046-019-1517-0 DO - 10.1186/s13046-019-1517-0 ID - Bosco2020 ER - TY - JOUR AU - Vito, A. AU - El-Sayes, N. AU - Mossman, K. PY - 2020 DA - 2020// TI - Hypoxia-driven immune escape in the tumor microenvironment JO - Cells. VL - 9 UR - https://doi.org/10.3390/cells9040992 DO - 10.3390/cells9040992 ID - Vito2020 ER - TY - JOUR AU - Datta, M. AU - Coussens, L. M. AU - Nishikawa, H. PY - 2019 DA - 2019// TI - Reprogramming the tumor microenvironment to improve immunotherapy: emerging strategies and combination therapies JO - Am Soc Clin Oncol Educ VL - 39 UR - https://doi.org/10.1200/EDBK_237987 DO - 10.1200/EDBK_237987 ID - Datta2019 ER - TY - JOUR AU - Vuillefroy de Silly, R. AU - Dietrich, P. Y. AU - Walker, P. R. PY - 2016 DA - 2016// TI - Hypoxia and antitumor CD8(+) T cells: An incompatible alliance? JO - Oncoimmunology VL - 5 UR - https://doi.org/10.1080/2162402X.2016.1232236 DO - 10.1080/2162402X.2016.1232236 ID - Vuillefroy de Silly2016 ER - TY - JOUR AU - Damgaci, S. AU - Ibrahim-Hashim, A. AU - Enriquez-Navas, P. M. PY - 2018 DA - 2018// TI - Hypoxia and acidosis: immune suppressors and therapeutic targets JO - Immunology. VL - 154 UR - https://doi.org/10.1111/imm.12917 DO - 10.1111/imm.12917 ID - Damgaci2018 ER - TY - JOUR AU - Mpekris, F. AU - Voutouri, C. AU - Baish, J. W. PY - 2020 DA - 2020// TI - Combining microenvironment normalization strategies to improve cancer immunotherapy JO - Proc Natl Acad Sci U S A VL - 117 UR - https://doi.org/10.1073/pnas.1919764117 DO - 10.1073/pnas.1919764117 ID - Mpekris2020 ER - TY - JOUR AU - Doedens, A. L. AU - Phan, A. T. AU - Stradner, M. H. PY - 2013 DA - 2013// TI - Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen JO - Nat Immunol VL - 14 UR - https://doi.org/10.1038/ni.2714 DO - 10.1038/ni.2714 ID - Doedens2013 ER - TY - JOUR AU - Reyes, A. AU - Corrales, N. AU - Gálvez, N. M. S. PY - 2020 DA - 2020// TI - Contribution of hypoxia inducible factor-1 during viral infections JO - Virulence. VL - 11 UR - https://doi.org/10.1080/21505594.2020.1836904 DO - 10.1080/21505594.2020.1836904 ID - Reyes2020 ER - TY - JOUR AU - Dang, E. V. AU - Barbi, J. AU - Yang, H. Y. PY - 2011 DA - 2011// TI - Control of T(H)17/T (reg) balance by hypoxia-inducible factor 1 JO - Cell. VL - 146 UR - https://doi.org/10.1016/j.cell.2011.07.033 DO - 10.1016/j.cell.2011.07.033 ID - Dang2011 ER - TY - STD TI - Noman MZ, Hasmim M, Messai Y, et al. Hypoxia: a key player in antitumor immune response. A review in the theme: cellular responses to hypoxia. Am J Physiol Cell Physiol. 2015;309(9):569–79. ID - ref25 ER - TY - JOUR AU - Payen, V. L. AU - Porporato, P. E. AU - Baselet, B. PY - 2016 DA - 2016// TI - Metabolic changes associated with tumor metastasis, part 1: tumor pH, glycolysis and the pentose phosphate pathway JO - Cell Mol Life Sci VL - 73 UR - https://doi.org/10.1007/s00018-015-2098-5 DO - 10.1007/s00018-015-2098-5 ID - Payen2016 ER - TY - JOUR AU - Francis, A. AU - Venkatesh, G. H. AU - Zaarour, R. F. PY - 2018 DA - 2018// TI - Tumor hypoxia: a key determinant of microenvironment hostility and a major checkpoint during the antitumor response JO - Crit Rev Immunol VL - 38 UR - https://doi.org/10.1615/CritRevImmunol.2019030168 DO - 10.1615/CritRevImmunol.2019030168 ID - Francis2018 ER - TY - STD TI - Torres N, Regge MV, Secchiari F, et al. Restoration of antitumor immunity through anti-MICA antibodies elicited with a chimeric protein. J Immunother Cancer. 2020;8(1). ID - ref28 ER - TY - JOUR AU - Balsamo, M. AU - Manzini, C. AU - Pietra, G. PY - 2013 DA - 2013// TI - Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC JO - Eur J Immunol VL - 43 UR - https://doi.org/10.1002/eji.201343448 DO - 10.1002/eji.201343448 ID - Balsamo2013 ER - TY - JOUR AU - Labiano, S. AU - Palazon, A. AU - Melero, I. PY - 2015 DA - 2015// TI - Immune response regulation in the tumor microenvironment by hypoxia JO - Semin Oncol VL - 42 UR - https://doi.org/10.1053/j.seminoncol.2015.02.009 DO - 10.1053/j.seminoncol.2015.02.009 ID - Labiano2015 ER - TY - JOUR AU - Krzywinska, E. AU - Kantari-Mimoun, C. AU - Kerdiles, Y. PY - 2017 DA - 2017// TI - Loss of HIF-1α in natural killer cells inhibits tumour growth by stimulating non-productive angiogenesis JO - Nat Commun VL - 8 UR - https://doi.org/10.1038/s41467-017-01599-w DO - 10.1038/s41467-017-01599-w ID - Krzywinska2017 ER - TY - JOUR AU - Zhang, J. AU - Han, C. AU - Dai, H. PY - 2016 DA - 2016// TI - Hypoxia-inducible factor-2α limits natural killer T cell cytotoxicity in renal ischemia/reperfusion injury JO - J Am Soc Nephrol VL - 27 UR - https://doi.org/10.1681/ASN.2014121248 DO - 10.1681/ASN.2014121248 ID - Zhang2016 ER - TY - JOUR AU - Yilmaz, A. AU - Ratka, J. AU - Rohm, I. PY - 2016 DA - 2016// TI - Decrease in circulating plasmacytoid dendritic cells during short-term systemic normobaric hypoxia JO - Eur J Clin Investig VL - 46 UR - https://doi.org/10.1111/eci.12416 DO - 10.1111/eci.12416 ID - Yilmaz2016 ER - TY - JOUR AU - Daniel, S. K. AU - Sullivan, K. M. AU - Labadie, K. P. PY - 2019 DA - 2019// TI - Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma JO - Clin Transl Med VL - 8 UR - https://doi.org/10.1186/s40169-019-0226-9 DO - 10.1186/s40169-019-0226-9 ID - Daniel2019 ER - TY - JOUR AU - Correale, P. AU - Rotundo, M. S. AU - Botta, C. PY - 2012 DA - 2012// TI - Tumor infiltration by T lymphocytes expressing chemokine receptor 7 (CCR7) is predictive of favorable outcome in patients with advanced colorectal carcinoma JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-10-3186 DO - 10.1158/1078-0432.CCR-10-3186 ID - Correale2012 ER - TY - JOUR AU - Köhler, T. AU - Reizis, B. AU - Johnson, R. S. PY - 2012 DA - 2012// TI - Influence of hypoxia-inducible factor 1α on dendritic cell differentiation and migration JO - Eur J Immunol VL - 42 UR - https://doi.org/10.1002/eji.201142053 DO - 10.1002/eji.201142053 ID - Köhler2012 ER - TY - JOUR AU - Blengio, F. AU - Raggi, F. AU - Pierobon, D. PY - 2013 DA - 2013// TI - The hypoxic environment reprograms the cytokine/chemokine expression profile of human mature dendritic cells JO - Immunobiology. VL - 218 UR - https://doi.org/10.1016/j.imbio.2012.02.002 DO - 10.1016/j.imbio.2012.02.002 ID - Blengio2013 ER - TY - JOUR AU - Chang, W. H. AU - Lai, A. G. PY - 2020 DA - 2020// TI - The hypoxic tumour microenvironment: a safe haven for immunosuppressive cells and a therapeutic barrier to overcome JO - Cancer Lett VL - 487 UR - https://doi.org/10.1016/j.canlet.2020.05.011 DO - 10.1016/j.canlet.2020.05.011 ID - Chang2020 ER - TY - JOUR AU - Takayama, T. AU - Morelli, A. E. AU - Onai, N. PY - 2001 DA - 2001// TI - Mammalian and viral IL-10 enhance C-C chemokine receptor 5 but down-regulate C-C chemokine receptor 7 expression by myeloid dendritic cells: impact on chemotactic responses and in vivo homing ability JO - J Immunol (Baltimore, Md : 1950) VL - 166 UR - https://doi.org/10.4049/jimmunol.166.12.7136 DO - 10.4049/jimmunol.166.12.7136 ID - Takayama2001 ER - TY - JOUR AU - Brombacher, E. C. AU - Everts, B. PY - 2020 DA - 2020// TI - Shaping of dendritic cell function by the metabolic micro-environment JO - Front Endocrinol VL - 11 UR - https://doi.org/10.3389/fendo.2020.00555 DO - 10.3389/fendo.2020.00555 ID - Brombacher2020 ER - TY - JOUR AU - Bosco, M. C. AU - Pierobon, D. AU - Blengio, F. PY - 2011 DA - 2011// TI - Hypoxia modulates the gene expression profile of immunoregulatory receptors in human mature dendritic cells: identification of TREM-1 as a novel hypoxic marker in vitro and in vivo JO - Blood. VL - 117 UR - https://doi.org/10.1182/blood-2010-06-292136 DO - 10.1182/blood-2010-06-292136 ID - Bosco2011 ER - TY - JOUR AU - Clambey, E. T. AU - McNamee, E. N. AU - Westrich, J. A. PY - 2012 DA - 2012// TI - Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa JO - Proc Natl Acad Sci U S A VL - 109 UR - https://doi.org/10.1073/pnas.1202366109 DO - 10.1073/pnas.1202366109 ID - Clambey2012 ER - TY - JOUR AU - Lee, J. H. AU - Elly, C. AU - Park, Y. PY - 2015 DA - 2015// TI - E3 ubiquitin ligase VHL regulates hypoxia-inducible factor-1α to maintain regulatory T cell stability and suppressive capacity JO - Immunity. VL - 42 UR - https://doi.org/10.1016/j.immuni.2015.05.016 DO - 10.1016/j.immuni.2015.05.016 ID - Lee2015 ER - TY - JOUR AU - Facciabene, A. AU - Peng, X. AU - Hagemann, I. S. PY - 2011 DA - 2011// TI - Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T (reg) cells JO - Nature. VL - 475 UR - https://doi.org/10.1038/nature10169 DO - 10.1038/nature10169 ID - Facciabene2011 ER - TY - JOUR AU - Ren, L. AU - Yu, Y. AU - Wang, L. PY - 2016 DA - 2016// TI - Hypoxia-induced CCL28 promotes recruitment of regulatory T cells and tumor growth in liver cancer JO - Oncotarget. VL - 7 UR - https://doi.org/10.18632/oncotarget.12409 DO - 10.18632/oncotarget.12409 ID - Ren2016 ER - TY - JOUR AU - Wu, Q. AU - Chen, J. X. AU - Chen, Y. PY - 2018 DA - 2018// TI - The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation JO - Cell Death Dis VL - 9 UR - https://doi.org/10.1038/s41419-018-0267-9 DO - 10.1038/s41419-018-0267-9 ID - Wu2018 ER - TY - JOUR AU - Yan, M. AU - Jene, N. AU - Byrne, D. PY - 2011 DA - 2011// TI - Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers JO - Breast Cancer Res VL - 13 UR - https://doi.org/10.1186/bcr2869 DO - 10.1186/bcr2869 ID - Yan2011 ER - TY - JOUR AU - Hasmim, M. AU - Noman, M. Z. AU - Messai, Y. PY - 2013 DA - 2013// TI - Cutting edge: Hypoxia-induced Nanog favors the intratumoral infiltration of regulatory T cells and macrophages via direct regulation of TGF-β1 JO - J Immunol (Baltimore, Md : 1950) VL - 191 UR - https://doi.org/10.4049/jimmunol.1302140 DO - 10.4049/jimmunol.1302140 ID - Hasmim2013 ER - TY - JOUR AU - Dysthe, M. AU - Parihar, R. PY - 2020 DA - 2020// TI - Myeloid-derived suppressor cells in the tumor microenvironment JO - Adv Exp Med Biol VL - 1224 UR - https://doi.org/10.1007/978-3-030-35723-8_8 DO - 10.1007/978-3-030-35723-8_8 ID - Dysthe2020 ER - TY - JOUR AU - Hou, A. AU - Hou, K. AU - Huang, Q. PY - 2020 DA - 2020// TI - Targeting myeloid-derived suppressor cell, a promising strategy to overcome resistance to immune checkpoint inhibitors JO - Front Immunol VL - 11 UR - https://doi.org/10.3389/fimmu.2020.00783 DO - 10.3389/fimmu.2020.00783 ID - Hou2020 ER - TY - JOUR AU - Chiu, D. K. AU - Xu, I. M. AU - Lai, R. K. PY - 2016 DA - 2016// TI - Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26 JO - Hepatology (Baltimore, Md) VL - 64 UR - https://doi.org/10.1002/hep.28655 DO - 10.1002/hep.28655 ID - Chiu2016 ER - TY - JOUR AU - Chiu, D. K. AU - Tse, A. P. AU - Xu, I. M. PY - 2017 DA - 2017// TI - Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma JO - Nat Commun VL - 8 UR - https://doi.org/10.1038/s41467-017-00530-7 DO - 10.1038/s41467-017-00530-7 ID - Chiu2017 ER - TY - JOUR AU - Noman, M. Z. AU - Janji, B. AU - Hu, S. PY - 2015 DA - 2015// TI - Tumor-promoting effects of myeloid-derived suppressor cells are potentiated by hypoxia-induced expression of miR-210 JO - Cancer Res VL - 75 UR - https://doi.org/10.1158/0008-5472.CAN-15-0405 DO - 10.1158/0008-5472.CAN-15-0405 ID - Noman2015 ER - TY - JOUR AU - Kumar, V. AU - Cheng, P. AU - Condamine, T. PY - 2016 DA - 2016// TI - CD45 phosphatase inhibits STAT3 transcription factor activity in myeloid cells and promotes tumor-associated macrophage differentiation JO - Immunity. VL - 44 UR - https://doi.org/10.1016/j.immuni.2016.01.014 DO - 10.1016/j.immuni.2016.01.014 ID - Kumar2016 ER - TY - JOUR AU - Vitale, I. AU - Manic, G. AU - Coussens, L. M. PY - 2019 DA - 2019// TI - Macrophages and metabolism in the tumor microenvironment JO - Cell Metab VL - 30 UR - https://doi.org/10.1016/j.cmet.2019.06.001 DO - 10.1016/j.cmet.2019.06.001 ID - Vitale2019 ER - TY - STD TI - Komohara Y, Fujiwara Y, Ohnishi K, et al. Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy. Adv Drug Delivery Rev. 2016;99(Pt B):180–185. ID - ref56 ER - TY - JOUR AU - Müller, S. AU - Kohanbash, G. AU - Liu, S. J. PY - 2017 DA - 2017// TI - Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment JO - Genome Biol VL - 18 UR - https://doi.org/10.1186/s13059-017-1362-4 DO - 10.1186/s13059-017-1362-4 ID - Müller2017 ER - TY - JOUR AU - Colegio, O. R. AU - Chu, N. -. Q. AU - Szabo, A. L. PY - 2014 DA - 2014// TI - Functional polarization of tumour-associated macrophages by tumour-derived lactic acid JO - Nature. VL - 513 UR - https://doi.org/10.1038/nature13490 DO - 10.1038/nature13490 ID - Colegio2014 ER - TY - JOUR AU - Liu, N. AU - Luo, J. AU - Kuang, D. PY - 2019 DA - 2019// TI - Lactate inhibits ATP6V0d2 expression in tumor-associated macrophages to promote HIF-2α-mediated tumor progression JO - J Clin Invest VL - 129 UR - https://doi.org/10.1172/JCI123027 DO - 10.1172/JCI123027 ID - Liu2019 ER - TY - JOUR AU - Ivashkiv, L. B. PY - 2020 DA - 2020// TI - The hypoxia-lactate axis tempers inflammation JO - Nat Rev Immunol VL - 20 UR - https://doi.org/10.1038/s41577-019-0259-8 DO - 10.1038/s41577-019-0259-8 ID - Ivashkiv2020 ER - TY - JOUR AU - Zhang, D. AU - Tang, Z. AU - Huang, H. PY - 2019 DA - 2019// TI - Metabolic regulation of gene expression by histone lactylation JO - Nature. VL - 574 UR - https://doi.org/10.1038/s41586-019-1678-1 DO - 10.1038/s41586-019-1678-1 ID - Zhang2019 ER - TY - JOUR AU - Zhu, H. AU - Wang, D. AU - Liu, Y. PY - 2013 DA - 2013// TI - Role of the hypoxia-inducible factor-1 alpha induced autophagy in the conversion of non-stem pancreatic cancer cells into CD133+ pancreatic cancer stem-like cells JO - Cancer Cell Int VL - 13 UR - https://doi.org/10.1186/1475-2867-13-119 DO - 10.1186/1475-2867-13-119 ID - Zhu2013 ER - TY - STD TI - Zarrilli G, Businello G, Dieci MV, et al. The Tumor Microenvironment of Primitive and Metastatic Breast Cancer: Implications for Novel Therapeutic Strategies. Int J Mol Sci. 2020:21. ID - ref63 ER - TY - JOUR AU - Barsoum, I. B. AU - Smallwood, C. A. AU - Siemens, D. R. PY - 2014 DA - 2014// TI - A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells JO - Cancer Res VL - 74 UR - https://doi.org/10.1158/0008-5472.CAN-13-0992 DO - 10.1158/0008-5472.CAN-13-0992 ID - Barsoum2014 ER - TY - JOUR AU - Noman, M. Z. AU - Desantis, G. AU - Janji, B. PY - 2014 DA - 2014// TI - PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation JO - J Exp Med VL - 211 UR - https://doi.org/10.1084/jem.20131916 DO - 10.1084/jem.20131916 ID - Noman2014 ER - TY - JOUR AU - Messai, Y. AU - Gad, S. AU - Noman, M. Z. PY - 2016 DA - 2016// TI - Renal cell carcinoma programmed death-ligand 1, a new direct target of hypoxia-inducible Factor-2 alpha, is regulated by von Hippel-Lindau gene mutation status JO - Eur Urol VL - 70 UR - https://doi.org/10.1016/j.eururo.2015.11.029 DO - 10.1016/j.eururo.2015.11.029 ID - Messai2016 ER - TY - JOUR AU - Pinato, D. J. AU - Black, J. R. AU - Trousil, S. PY - 2017 DA - 2017// TI - Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: relationship with the hypoxic response, immune evasion and malignant behavior JO - Oncoimmunology. VL - 6 UR - https://doi.org/10.1080/2162402X.2017.1358332 DO - 10.1080/2162402X.2017.1358332 ID - Pinato2017 ER - TY - JOUR AU - Curigliano, G. AU - Criscitiello, C. AU - Gelao, L. PY - 2013 DA - 2013// TI - Molecular pathways: human leukocyte antigen G (HLA-G) JO - Clin Cancer Res VL - 19 UR - https://doi.org/10.1158/1078-0432.CCR-12-3697 DO - 10.1158/1078-0432.CCR-12-3697 ID - Curigliano2013 ER - TY - STD TI - Garziera M, Scarabel L, Toffoli G. Hypoxic Modulation of HLA-G Expression through the Metabolic Sensor HIF-1 in Human Cancer Cells. J Immunol Res. 2017:4587520. ID - ref69 ER - TY - JOUR AU - Mouillot, G. AU - Marcou, C. AU - Zidi, I. PY - 2007 DA - 2007// TI - Hypoxia modulates HLA-G gene expression in tumor cells JO - Hum Immunol VL - 68 UR - https://doi.org/10.1016/j.humimm.2006.10.016 DO - 10.1016/j.humimm.2006.10.016 ID - Mouillot2007 ER - TY - JOUR AU - Yaghi, L. AU - Poras, I. AU - Simoes, R. T. PY - 2016 DA - 2016// TI - Hypoxia inducible factor-1 mediates the expression of the immune checkpoint HLA-G in glioma cells through hypoxia response element located in exon 2 JO - Oncotarget. VL - 7 UR - https://doi.org/10.18632/oncotarget.11628 DO - 10.18632/oncotarget.11628 ID - Yaghi2016 ER - TY - JOUR AU - Sasaki, T. AU - Kanaseki, T. AU - Shionoya, Y. PY - 2016 DA - 2016// TI - Microenvironmental stresses induce HLA-E/Qa-1 surface expression and thereby reduce CD8(+) T-cell recognition of stressed cells JO - Eur J Immunol VL - 46 UR - https://doi.org/10.1002/eji.201545835 DO - 10.1002/eji.201545835 ID - Sasaki2016 ER - TY - JOUR AU - Logtenberg, M. E. W. AU - Scheeren, F. A. AU - Schumacher, T. N. PY - 2020 DA - 2020// TI - The CD47-SIRPα immune checkpoint JO - Immunity. VL - 52 UR - https://doi.org/10.1016/j.immuni.2020.04.011 DO - 10.1016/j.immuni.2020.04.011 ID - Logtenberg2020 ER - TY - JOUR AU - Zhang, H. AU - Lu, H. AU - Xiang, L. PY - 2015 DA - 2015// TI - HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells JO - Proc Natl Acad Sci U S A VL - 112 UR - https://doi.org/10.1073/pnas.1520032112 DO - 10.1073/pnas.1520032112 ID - Zhang2015 ER - TY - JOUR AU - Michaels, A. D. AU - Newhook, T. E. AU - Adair, S. J. PY - 2018 DA - 2018// TI - CD47 blockade as an adjuvant immunotherapy for Resectable pancreatic Cancer JO - Clin Cancer Res VL - 24 UR - https://doi.org/10.1158/1078-0432.CCR-17-2283 DO - 10.1158/1078-0432.CCR-17-2283 ID - Michaels2018 ER - TY - JOUR AU - Liu, X. AU - Pu, Y. AU - Cron, K. PY - 2015 DA - 2015// TI - CD47 blockade triggers T cell-mediated destruction of immunogenic tumors JO - Nat Med VL - 21 UR - https://doi.org/10.1038/nm.3931 DO - 10.1038/nm.3931 ID - Liu2015 ER - TY - JOUR AU - Palazón, A. AU - Martínez-Forero, I. AU - Teijeira, A. PY - 2012 DA - 2012// TI - The HIF-1α hypoxia response in tumor-infiltrating T lymphocytes induces functional CD137 (4-1BB) for immunotherapy JO - Cancer Discov VL - 2 UR - https://doi.org/10.1158/2159-8290.CD-11-0314 DO - 10.1158/2159-8290.CD-11-0314 ID - Palazón2012 ER - TY - JOUR AU - Lee, P. AU - Chandel, N. S. AU - Simon, M. C. PY - 2020 DA - 2020// TI - Cellular adaptation to hypoxia through hypoxia inducible factors and beyond JO - Nat Rev Mol Cell Biol VL - 21 UR - https://doi.org/10.1038/s41580-020-0227-y DO - 10.1038/s41580-020-0227-y ID - Lee2020 ER - TY - JOUR AU - Noman, M. Z. AU - Buart, S. AU - Pelt, J. PY - 2009 DA - 2009// TI - The cooperative induction of hypoxia-inducible factor-1 alpha and STAT3 during hypoxia induced an impairment of tumor susceptibility to CTL-mediated cell lysis JO - J Immunol (Baltimore, Md : 1950) VL - 182 UR - https://doi.org/10.4049/jimmunol.0800854 DO - 10.4049/jimmunol.0800854 ID - Noman2009 ER - TY - JOUR AU - Noman, M. Z. AU - Janji, B. AU - Kaminska, B. PY - 2011 DA - 2011// TI - Blocking hypoxia-induced autophagy in tumors restores cytotoxic T-cell activity and promotes regression JO - Cancer Res VL - 71 UR - https://doi.org/10.1158/0008-5472.CAN-11-1094 DO - 10.1158/0008-5472.CAN-11-1094 ID - Noman2011 ER - TY - JOUR AU - Hasmim, M. AU - Noman, M. Z. AU - Lauriol, J. PY - 2011 DA - 2011// TI - Hypoxia-dependent inhibition of tumor cell susceptibility to CTL-mediated lysis involves NANOG induction in target cells JO - J Immunol (Baltimore, Md : 1950) VL - 187 UR - https://doi.org/10.4049/jimmunol.1101011 DO - 10.4049/jimmunol.1101011 ID - Hasmim2011 ER - TY - JOUR AU - Hasmim, M. AU - Janji, B. AU - Khaled, M. PY - 2017 DA - 2017// TI - Cutting Edge: NANOG Activates Autophagy under Hypoxic Stress by Binding to BNIP3L Promoter JO - J Immunol (Baltimore, Md : 1950) VL - 198 UR - https://doi.org/10.4049/jimmunol.1600981 DO - 10.4049/jimmunol.1600981 ID - Hasmim2017 ER - TY - JOUR AU - Viry, E. AU - Baginska, J. AU - Berchem, G. PY - 2014 DA - 2014// TI - Autophagic degradation of GZMB/granzyme B: a new mechanism of hypoxic tumor cell escape from natural killer cell-mediated lysis JO - Autophagy. VL - 10 UR - https://doi.org/10.4161/auto.26924 DO - 10.4161/auto.26924 ID - Viry2014 ER - TY - JOUR AU - Messai, Y. AU - Noman, M. Z. AU - Hasmim, M. PY - 2014 DA - 2014// TI - ITPR1 protects renal cancer cells against natural killer cells by inducing autophagy JO - Cancer Res VL - 74 UR - https://doi.org/10.1158/0008-5472.CAN-14-0303 DO - 10.1158/0008-5472.CAN-14-0303 ID - Messai2014 ER - TY - STD TI - Messai Y, Noman MZ, Janji B, et al. The autophagy sensor ITPR1 protects renal carcinoma cells from NK-mediated killing. Autophagy. 2015:0. ID - ref85 ER - TY - JOUR AU - Terry, S. AU - Faouzi Zaarour, R. AU - Hassan Venkatesh, G. PY - 2018 DA - 2018// TI - Role of hypoxic stress in regulating tumor immunogenicity, resistance and plasticity JO - Int J Mol Sci VL - 19 UR - https://doi.org/10.3390/ijms19103044 DO - 10.3390/ijms19103044 ID - Terry2018 ER - TY - JOUR AU - Jayaprakash, P. AU - Ai, M. AU - Liu, A. PY - 2018 DA - 2018// TI - Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy JO - J Clin Invest VL - 128 UR - https://doi.org/10.1172/JCI96268 DO - 10.1172/JCI96268 ID - Jayaprakash2018 ER - TY - JOUR AU - Hendricksen, K. AU - Cornel, E. B. AU - Reijke, T. M. PY - 2012 DA - 2012// TI - Phase 2 study of adjuvant intravesical instillations of apaziquone for high risk nonmuscle invasive bladder cancer JO - J Urol VL - 187 UR - https://doi.org/10.1016/j.juro.2011.11.101 DO - 10.1016/j.juro.2011.11.101 ID - Hendricksen2012 ER - TY - JOUR AU - Sun, X. AU - Kanwar, J. R. AU - Leung, E. PY - 2001 DA - 2001// TI - Gene transfer of antisense hypoxia inducible factor-1 alpha enhances the therapeutic efficacy of cancer immunotherapy JO - Gene Ther VL - 8 UR - https://doi.org/10.1038/sj.gt.3301388 DO - 10.1038/sj.gt.3301388 ID - Sun2001 ER - TY - JOUR AU - Kheshtchin, N. AU - Arab, S. AU - Ajami, M. PY - 2016 DA - 2016// TI - Inhibition of HIF-1α enhances anti-tumor effects of dendritic cell-based vaccination in a mouse model of breast cancer JO - Cancer Immunol Immunother VL - 65 UR - https://doi.org/10.1007/s00262-016-1879-5 DO - 10.1007/s00262-016-1879-5 ID - Kheshtchin2016 ER - TY - STD TI - Lazarus D, Peters C, Stockmann A, et al. Abstract 3209: CRLX101, an investigational nanoparticle-drug conjugate of camptothecin, demonstrates synergy with immunotherapy agents in preclinical models. 2016;76(14 Supplement):3209-. ID - ref91 ER - TY - JOUR AU - Chang, D. K. AU - Moniz, R. J. AU - Xu, Z. PY - 2015 DA - 2015// TI - Human anti-CAIX antibodies mediate immune cell inhibition of renal cell carcinoma in vitro and in a humanized mouse model in vivo JO - Mol Cancer VL - 14 UR - https://doi.org/10.1186/s12943-015-0384-3 DO - 10.1186/s12943-015-0384-3 ID - Chang2015 ER - TY - JOUR AU - Chafe, S. C. AU - McDonald, P. C. AU - Saberi, S. PY - 2019 DA - 2019// TI - Targeting hypoxia-induced carbonic anhydrase IX enhances immune-checkpoint blockade locally and systemically JO - Cancer immunology research. VL - 7 UR - https://doi.org/10.1158/2326-6066.CIR-18-0657 DO - 10.1158/2326-6066.CIR-18-0657 ID - Chafe2019 ER - TY - JOUR AU - Ma, S. R. AU - Deng, W. W. AU - Liu, J. F. PY - 2017 DA - 2017// TI - Blockade of adenosine A2A receptor enhances CD8(+) T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma JO - Mol Cancer VL - 16 UR - https://doi.org/10.1186/s12943-017-0665-0 DO - 10.1186/s12943-017-0665-0 ID - Ma2017 ER - TY - JOUR AU - Hatfield, S. M. AU - Kjaergaard, J. AU - Lukashev, D. PY - 2015 DA - 2015// TI - Immunological mechanisms of the antitumor effects of supplemental oxygenation JO - Sci Transl Med VL - 7 UR - https://doi.org/10.1126/scitranslmed.aaa1260 DO - 10.1126/scitranslmed.aaa1260 ID - Hatfield2015 ER - TY - JOUR AU - Scharping, N. E. AU - Menk, A. V. AU - Whetstone, R. D. PY - 2017 DA - 2017// TI - Efficacy of PD-1 blockade is potentiated by metformin-induced reduction of tumor hypoxia JO - Cancer Immunol Res VL - 5 UR - https://doi.org/10.1158/2326-6066.CIR-16-0103 DO - 10.1158/2326-6066.CIR-16-0103 ID - Scharping2017 ER - TY - JOUR AU - Munn, L. L. AU - Jain, R. K. PY - 2019 DA - 2019// TI - Vascular regulation of antitumor immunity JO - Science (New York, NY) VL - 365 UR - https://doi.org/10.1126/science.aaw7875 DO - 10.1126/science.aaw7875 ID - Munn2019 ER - TY - STD TI - Llovet JM, Kudo M, Cheng AL, et al. Lenvatinib (len) plus pembrolizumab (pembro) for the first-line treatment of patients (pts) with advanced hepatocellular carcinoma (HCC): Phase 3 LEAP-002 study. 2019;37(15_suppl):TPS4152-TPS. ID - ref98 ER - TY - JOUR AU - Hunter, F. W. AU - Wouters, B. G. AU - Wilson, W. R. PY - 2016 DA - 2016// TI - Hypoxia-activated prodrugs: paths forward in the era of personalised medicine JO - Br J Cancer VL - 114 UR - https://doi.org/10.1038/bjc.2016.79 DO - 10.1038/bjc.2016.79 ID - Hunter2016 ER - TY - JOUR AU - Phillips, R. M. AU - Hendriks, H. R. AU - Peters, G. J. PY - 2013 DA - 2013// TI - EO9 (Apaziquone): from the clinic to the laboratory and back again JO - Br J Pharmacol VL - 168 UR - https://doi.org/10.1111/j.1476-5381.2012.01996.x DO - 10.1111/j.1476-5381.2012.01996.x ID - Phillips2013 ER - TY - JOUR AU - Bhattarai, D. AU - Xu, X. AU - Lee, K. PY - 2018 DA - 2018// TI - Hypoxia-inducible factor-1 (HIF-1) inhibitors from the last decade (2007 to 2016): a "structure-activity relationship" perspective JO - Med Res Rev VL - 38 UR - https://doi.org/10.1002/med.21477 DO - 10.1002/med.21477 ID - Bhattarai2018 ER - TY - STD TI - Parayath N, Padmakumar S, Nair SV, et al. Strategies for targeting cancer immunotherapy through modulation of the tumor microenvironment. Regen Eng Transl Med. 2020;6(1):29–49. ID - ref102 ER - TY - JOUR AU - Feng, L. L. AU - Cai, Y. Q. AU - Zhu, M. C. PY - 2020 DA - 2020// TI - The yin and yang functions of extracellular ATP and adenosine in tumor immunity JO - Cancer Cell Int VL - 20 UR - https://doi.org/10.1186/s12935-020-01195-x DO - 10.1186/s12935-020-01195-x ID - Feng2020 ER - TY - JOUR AU - Leone, R. D. AU - Horton, M. R. AU - Powell, J. D. PY - 2015 DA - 2015// TI - Something in the air: hyperoxic conditioning of the tumor microenvironment for enhanced immunotherapy JO - Cancer Cell VL - 27 UR - https://doi.org/10.1016/j.ccell.2015.03.014 DO - 10.1016/j.ccell.2015.03.014 ID - Leone2015 ER - TY - JOUR AU - Haibe, Y. AU - Kreidieh, M. AU - Hajj, H. PY - 2020 DA - 2020// TI - Resistance mechanisms to anti-angiogenic therapies in Cancer JO - Front Oncol VL - 10 UR - https://doi.org/10.3389/fonc.2020.00221 DO - 10.3389/fonc.2020.00221 ID - Haibe2020 ER - TY - JOUR AU - Hodi, F. S. AU - Lawrence, D. AU - Lezcano, C. PY - 2014 DA - 2014// TI - Bevacizumab plus ipilimumab in patients with metastatic melanoma JO - Cancer Immunol Res VL - 2 UR - https://doi.org/10.1158/2326-6066.CIR-14-0053 DO - 10.1158/2326-6066.CIR-14-0053 ID - Hodi2014 ER - TY - JOUR AU - Wallin, J. J. AU - Bendell, J. C. AU - Funke, R. PY - 2016 DA - 2016// TI - Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma JO - Nat Commun VL - 7 UR - https://doi.org/10.1038/ncomms12624 DO - 10.1038/ncomms12624 ID - Wallin2016 ER - TY - JOUR AU - Goel, S. AU - Duda, D. G. AU - Xu, L. PY - 2011 DA - 2011// TI - Normalization of the vasculature for treatment of cancer and other diseases JO - Physiol Rev VL - 91 UR - https://doi.org/10.1152/physrev.00038.2010 DO - 10.1152/physrev.00038.2010 ID - Goel2011 ER - TY - STD TI - Liapis E, Klemm U, Karlas A, et al. Resolution of spatial and temporal heterogeneity in bevacizumab-treated breast tumors by eigenspectra multispectral optoacoustic tomography. Cancer Res. 2020. ID - ref109 ER - TY - JOUR AU - Conley, S. J. AU - Gheordunescu, E. AU - Kakarala, P. PY - 2012 DA - 2012// TI - Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia JO - Proc Natl Acad Sci U S A VL - 109 UR - https://doi.org/10.1073/pnas.1018866109 DO - 10.1073/pnas.1018866109 ID - Conley2012 ER - TY - JOUR AU - Fukumura, D. AU - Kloepper, J. AU - Amoozgar, Z. PY - 2018 DA - 2018// TI - Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges JO - Nat Rev Clin Oncol VL - 15 UR - https://doi.org/10.1038/nrclinonc.2018.29 DO - 10.1038/nrclinonc.2018.29 ID - Fukumura2018 ER -